ClinicalTrials.Veeva

Menu
C

Centrum Medyczne EuroMedis | Szczecin, Poland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Donanemab
LY3002813
AVP-786
LY3372689
Orforglipron
Brenipatide
Deudextromethorphan Hydrobromide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 7 total trials

A Study of Brenipatide in Adult Participants With Major Depressive Disorder (RENEW-MDD-1)

This study evaluates the safety and efficacy of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC in delaying th...

Not yet enrolling
Depressive Disorder, Major
Drug: Placebo
Drug: Brenipatide

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The study duration includ...

Enrolling
Alzheimer Disease
Mental Disorders
Drug: Placebo
Drug: Donanemab

The GZPS master protocol will support two independent studies, J2A-MC-GZS1 and J2A-MC-GZS2. Each study will see how well and safely orforglipron work...

Enrolling
Urinary Incontinence,Stress
Drug: Placebo
Drug: Orforglipron

Trial sponsors

Lilly logo
Otsuka logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems